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The effect of temperature, pH, and free [Mg2] on the
apparent equilibrium constant of pyruvate kinase
(phosphoenol transphosphorylase) (EC 2.7.1.40) was in-
vestigated. The apparent equilibrium constant, K, for
the biochemical reaction P-enolpyruvate  ADP  ATP
 Pyr was defined as K [ATP][Pyr]/[ADP][P-enolpyru-
vate], where each reactant represents the sum of all the
ionic and metal complexed species in M. The K at pH 7.0,
1.0 mM free Mg2 and I of 0.25 M was 3.89  104 (n  8) at
25 °C. The standard apparent enthalpy (H°) for the
biochemical reaction was4.31 kJmol1 in the direction
of ATP formation. The corresponding standard appar-
ent entropy (S°) was 73.4 J K1 mol1. The H° and
S° values for the reference reaction, P-enolpyruvate3
ADP3 H ATP4 Pyr1, were6.43 kJmol1 and
180 J K1 mol1, respectively (5 to 38 °C). We examined
further the mass action ratio in rat heart and skeletal
muscle at rest and found that the pyruvate kinase reac-
tion in vivo was close to equilibrium i.e. within a factor
of about 3 to 6 of K in the direction of ATP at the same
pH, free [Mg2], and T. We conclude that the pyruvate
kinase reaction may be reversed under some conditions
in vivo, a finding that challenges the long held dogma
that the reaction is displaced far from equilibrium.
Pyruvate kinase (phosphoenol transphosphorylase) (EC
2.7.1.40) catalyzes the magnesium- and potassium-dependent
transphosphorylation between phosphoenolpyruvate (P-enol-
pyruvate)1 and ADP according to Reaction 1 (1).
PEP ADP ATP Pyr
REACTION 1
The enzymatic transfer of phosphate from P-enolpyruvate to ATP
was first described in 1934 by Parnas, Ostern, and Mann (2).
Despite early statements of Meyerhof et al. (3) that the reaction
was irreversible, Lardy and Ziegler (4) experimentally showed in
rat muscle extracts its reversibility in 1945 from the exchange of
32P between P-enolpyruvate and ATP. These workers further
showed that P-enolpyruvate could be synthesized directly from
pyruvate in a system where ATP was constantly being regener-
ated and that the rate of reaction increased with increasing
potassium concentration (4, 5). The reversibility of the reaction in
muscle extracts was subsequently shown by Krimsky (6) and
McQuate and Utter (7) in 1959 and again by Dyson et al. (8) in
1975.
The more important question, however, is whether pyruvate
kinase can be reversed in intact tissues. Can glycolysis be
reversed at pyruvate kinase and glycogen form from lactate in
skeletal muscle in vivo (7, 9–14)? Because the early thermody-
namic study of McQuate and Utter (7) indicated an unfavorable
equilibrium at the pyruvate kinase step, Krebs proposed a
bypass reaction via pyruvate carboxylase (EC 6.4.1.1). Pyru-
vate carboxylase catalyzes the ATP-driven formation of oxalo-
acetate from pyruvate and HCO3
 and P-enolpyruvate car-
boxykinase (PEPCK) (EC 4.1.1.49), which then converts
oxaloacetate to P-enolpyruvate (15). Although this pathway is
known to occur in liver (and kidney) (16, 17), it remains unclear
whether the enzymes are present in skeletal muscle or heart
(18).
On closer examination of the otherwise excellent study of
McQuate and Utter (7), there are a number of unavoidable
limitations to their analysis. For example, in the 1950s there
was considerable uncertainty about the apparent magnesium
and acid binding constants for the ATP and ADP series, the
binding of ADP in skeletal muscle, and the problem of meas-
uring accurately low concentrations of metabolites in intact
tissue. There was also a lack of computing power to solve the
system of simultaneous equations defining the reaction in
vitro. These limitations, along with the high sensitivity of the
reaction to varying pH and free [Mg2], have impeded a de-
tailed study into the thermodynamics of the reaction. The aim
of this study was to examine the thermodynamics of the pyru-
vate kinase reaction and estimate the apparent equilibrium
position in heart and skeletal muscle using the methodologies
described for our earlier work on creatine kinase and arginine
kinase (19, 20). The present study provides strong evidence
that the pyruvate kinase equilibrium may be reversed in vivo,
which helps explain otherwise perplexing data on the reversal
of glycolysis and glycogen synthesis following exercise.
MATERIALS AND METHODS
Enzymes and Chemicals—Pyruvate kinase (EC 2.7.1.40) from rabbit
skeletal muscle was purchased as the 3.2 M ammonium sulfate suspen-
sions from Roche Molecular Biochemicals. Pyruvate-monosodium salt,
ATP-crystallized disodium salt, ADP-disodium salt, NADH-monoso-
dium salt (grade 1) and NADP-disodium salt (98%), creatine kinase,
glucose-6-phosphate dehydrogenase, hexokinase from yeast, and lac-
tate dehydrogenase from beef heart were obtained from Roche Molec-
ular Biochemicals. Pyruvate kinase (lyophilized powder from rabbit
skeletal muscle), P-enolpyruvate-monopotassium salt, D-glucose, imid-
azole (low fluorescence blank 0.002%) and trizma-base (Tris[hydroxy-
methyl]-aminomethane), phosphate-potassium salt (monobasic and di-
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basic), and EDTA (acid form) and hydrogen peroxide 30% (9.8 M) were
purchased from Sigma. All other chemicals were reagent grade.
Equilibrium Studies—The pyruvate kinase reaction was carried out
from the forward and reverse direction in a reaction buffer containing
50 mM potassium phosphate, pH 7.0, 110 mM potassium chloride, and
4.75 mM magnesium chloride at 25 °C. For the forward direction, the
reaction buffer also contained 0.5 mM ADP, 0.5 mM P-enolpyruvate, 4.3
mM ATP, and 4.7 mM pyruvate. For the reverse direction the reaction
buffer also contained 5.0 mM pyruvate and 5.1 mM ATP. A 10-ml aliquot
of each reaction buffer was placed in separate 10-ml conical bottom
reaction vials with V-shaped magnetic stirring bars (Pierce). These
reaction vials were sealed with removable Teflon caps and placed in a
Neslab RTE100 temperature-controlled water bath. Experimental tem-
perature was maintained  0.1 °C. A water/air-powered magnetic stir
motor was used to mix the reaction vials throughout the experiment.
Reaction buffer pH was monitored using a Radiometer Copenhagen
PHM 93 reference pH meter, with a Radiometer Copenhagen PHC 2005
electrode. The procedure has been described in detail in Teague and
Dobson (19, 20).
During the temperature experiments the pH meter was calibrated at
each experimental temperature using the Radiometer Copenhagen 47.5
mM phosphate S11M004, pH 7.0  0.01, at 25 °C. This pH standard had
a temperature coefficient (pH/t °C) of 0.0028, which was appropri-
ate for our reaction buffers that contained 50 mM phosphate. The vials
containing the reaction buffer were allowed 20 min to reach tempera-
ture prior to initiation of the reaction with enzyme. The pyruvate kinase
enzyme was prepared by dissolving 10 mg of the lyophilized powder
(5000 units per mg) in 1.0 ml of 50 mM phosphate buffer at pH 7.0, and
10 l of this preparation was added to the 10 ml of reaction buffer to
initiate the reaction (final activity of 5 units/ml at 25 °C). After 1 h of
reaction time, a 1.0-ml aliquot was transferred from the reacti-vial to a
Centricon-30 spin filter (Amicon) maintained at the experimental tem-
perature in the water bath. The spin filter was then placed into a
temperature-controlled rotor and centrifuged at 4000  g for 5 min. The
enzyme-free filtrate (300 l) containing the reaction buffer at equilib-
rium was removed and kept at 80 °C until analysis the following day.
To ensure that the temperature was maintained at a constant through-
out the centrifugation, great care was taken to keep the centrifuge and
rotors at the appropriate experimental temperature. After completing
the first experiment at 5 °C, the bath temperature was raised to 15 °C,
and identical procedures were used for equilibration and sampling. The
process was then repeated at 25, 35, and 45 °C. Experiments studying
the variation of the K and pH were carried out in a similar manner at
25 °C.
Measurement of ATP, Pyruvate, ADP, and P-enolpyruvate in Equi-
librium Mixtures—Enzymatic assays of ATP and pyruvate were carried
out according to the procedures described in Lowry and Passonneau
(40) with the following modifications: ATP was measured spectropho-
tometrically in 50 mM Tris-HCl, pH 8.1, 0.4 mM D-glucose, 1 mM MgCl2,
0.3 mM NADP containing 0.35 units/ml glucose-6-phosphate dehydro-
genase. The reaction was initiated with 0.7 units/ml hexokinase and
complete in 5 to 10 min. Pyruvate was measured spectrophotometri-
cally in 50 mM phosphate buffer, pH 7.0 (30 mM K2HPO4, 20 mM
KH2PO4), and 0.1 mM NADH. The reaction was initiated by the addition
of 1.5 units/ml lactate dehydrogenase, and the reaction was complete in
5 to 10 min. P-enolpyruvate or ADP was measured by monitoring
NADH fluorescence in the equilibrium samples after pyruvate had been
removed by peroxide treatment. Pyruvate removal was essential, be-
cause high concentrations interfered with the accurate measurement of
the micromolar concentrations of P-enolpyruvate and ADP, a conse-
quence of the overall equilibrium strongly favoring pyruvate and ATP
formation.
Pyruvate was removed by heating 100 l of sample in 10  75-mm
tubes for 10 min at 60 °C in 50 mM imidazole, pH 7.5, and a 5:1 molar
excess of H2O2:pyruvate. Control experiments using standards showed
that 99–100% of the pyruvate was removed by the peroxide oxidation
step, without any effect on P-enolpyruvate or ADP concentrations; there
was a 100% recovery of P-enolpyruvate or ADP standards. The excess
peroxide was removed by the addition of 25 units/ml catalase (EC
1.11.1.6) to minimize reduction of NADH in subsequent enzymatic
measurements but was found not to be necessary in our measurements.
P-enolpyruvate or ADP was then measured by adding 1 ml of reagent
and the pyruvate kinase-lactate dehydrogenase coupled assay system
(21). Briefly, the reagent comprised a 50 mM phosphate buffer, pH 7.0
(30 mM Na2HPO4, 20 mM NaH2PO4), 2 mM MgCl2, 0.2 mM ADP, 0.2 mM
EDTA, 5 M NADH, catalase (25 units/ml), and lactate dehydrogenase
(50 l of 10 mg/ml/50 ml). An initial reading was taken, after which 10
l of pyruvate kinase (5 l 10 mg/ml of water) was added to the reaction
in a volume of 10 l (1.25 units) to measure the P-enolpyruvate. ADP
could be measured by the substitution of 0.2 mM P-enolpyruvate for the
ADP in the same reagent. The time for completion of either P-enolpyru-
vate or ADP measurement was 5 to 10 min. Standard curves were used
for quantify the measurements.
Acid-dissociation and Magnesium Binding Constants at Varying
Temperatures and I  0.25 M—The acid-dissociation constants and
magnesium binding constants for the ATP and ADP series, and for
phosphate, and their respective H° values (ionic strength  0) used in
this study can be found in Teague and Dobson (19) and Golding et al.
(23). The acid-dissociation constants were of the form HA  H  A
where Ka  [H
] [A]/[HA], and magnesium binding constants were of
the form Mg2  Ax  MgA(2  x) where Kb  [MgA
(2  x)]/[Mg2][Ax]
where HA is the acid, and A is its conjugate base. The method for
adjusting the equilibrium constants to 5, 15, 25, 35, and 45 °C at the
ionic strength of 0.25 M is also found in these papers. The Ka values
using a H° (I  0) of 4.00 kJmol1 for P-enolpyruvate were as
follows: 5.019  107 (5 °C), 4.727  107 (15 °C), 4.4700  107
(25 °C), 4.242  107 (35 °C), and 4.039  107 (45 °C) (22). The Kb
values using a H° (I  0) of 12.50 kJmol1 for P-enolpyruvate were
as follows: 1.253  102 (5 °C), 1.511  102 (15 °C), 1.800  102 (25 °C),
2.120  102 (35 °C), and 2.470  102 (45 °C) (22). Unfortunately we
could not find a H° (I  0) for acid or magnesium binding to pyruvate
and have used a Ka of 3.16  10
3 (5 to 45 °C) and a Kb of 6.3 (5 to 45 °C)
(22). The Kb was assumed to be the same as the calcium binding
constant. For such weak binding we would not expect a very large H°,2
and thus it would have little impact on our results.
Calculation of Free [Mg2] and the Concentration of Major Ionic
Species in Equilibrium Mixtures—Free [Mg2] refers to the concentra-
tion of ionized magnesium as opposed to magnesium bound to com-
pounds such as ATP or other phosphates. Free [Mg2], and the concen-
tration of major ionic species of reactants of the pyruvate kinase
reaction, were calculated using a computer program written in the
language of Mathematica (Wolfram Research). The details of the
method and system of equations can be found in Teague and Dobson
(19) and Golding et al. (23). Briefly, total concentrations of reactants of
the reaction at equilibrium, together with the total magnesium concen-
tration, ionic strength, and the acid-dissociation and metal binding
constants adjusted to specified ionic conditions, were substituted into a
system of simultaneous equations representing the pyruvate kinase
reaction under our experimental conditions. The solution of these si-
multaneous equations yields molar concentrations for the ionic species
of reactants present.
NMR Experiments: Determination of the Mass Action Ratio in
Situ—To assess the equilibrium position of the biochemical reaction of
pyruvate kinase (Reaction 1) in heart and skeletal muscle in situ, all the
reactants, as well as pH and free [Mg2], have to be measured or
calculated in the tissues. From these data, the mass action ratio can be
calculated and compared with the equilibrium constant determined in
the laboratory after adjustment to the tissue pH, free [Mg2] at 38 °C,
and ionic strength of 0.25 M.
Fourteen male Sprague-Dawley rats weighing 300–350 g were ob-
tained from the James Cook University breeding colony and housed in
the animal facility. Seven were prepared for heart measurements and
seven for muscle measurements. Rats were supplied with unrestricted
access to food and water. Animals were anesthetized with an intraperi-
toneal injection of sodium pentobarbital (60 mgkg rat weight1). The
left femoral artery and vein were cannulated with PE 50 tubing, and the
venous line was used for maintenance of anesthesia (15 mgml1 solu-
tion of sodium pentobarbital in 0.9% saline) whereas the arterial line
was for blood collection and continuous monitoring of blood pressure.
The details of the procedure are found in Hitchins et al. (24). Briefly,
animals were artificially ventilated on room air with a Harvard small
animal ventilator (Harvard Apparatus, South Natick, MA) to give a
blood pO2 of 90 mm Hg, a pCO2 of 40 mm Hg, and a pH of 7.4.
Blood (0.2 ml) was drawn from the arterial line and analyzed with the
Ciba-Corning 865 blood gas analyzer (Ciba Corning Diagnostic Corp.,
Medfield, MA) to ensure that blood gases were within the correct range.
For heart measurements a thoracotomy was performed, and a cus-
tom-built, flexible arm surface coil (9-mm outer diameter) tunable to 31P
was placed on the left ventricle. The coil was made of Teflon-coated
copper wire (1.25-mm thick) and was sufficiently flexible to follow the
movement of the heart and maintain contact, without excessive pres-
sure against the heart (24). For skeletal muscle measurements, anes-
thesia was maintained by delivering 1% isoflurane (Abbott Australasia,
2 R. Alberty, personal communication.













Kurnell, Australia) in compressed air via the ventilator at a rate of 0.5
liter/min. Like in the heart protocol, the animal was transferred to a
purpose-built Perspex cradle. The cradle was pre-fitted with a 37 °C
water-heated pad. The gastrocnemius was exposed, and the muscle was
carefully denuded of overlying tissue and covered with a plastic film to
prevent drying of exposed tissue. A three-turn surface coil (14-mm outer
diameter) tunable to 31P was placed on the center of the gastrocnemius
(25, 26).
31P NMR experiments were performed at 121.47 MHz in a 110-mm
horizontal bore Oxford 7.05-tesla superconducting magnet coupled to a
Varian INOVA NMR spectrometer (24). For heart, radiofrequency
pulses of 8-s duration at an approximate 40° flip angle were applied
with a 1-s interpulse delay. FIDs were acquired over 0.4 s with a total
of 1024 free induction delays averaged. An 8000-Hz spectral width was
used, and 6400 data points were obtained. A 10-Hz exponential line-
broadening factor was applied to 31P NMR spectra, which were fitted
using Varian Fitspec software. Following integration, all peaks were
multiplied by a saturation correction factor specific for each peak. These
factors were determined experimentally by comparing the peak inte-
grals of partially relaxed spectra, obtained using the acquisition param-
eters described above, to the peak integrals of fully relaxed spectra (20-s
interpulse delay). In heart, the mean correction factors for Pi, phospho-
creatine, and -ATP were 0.97  0.08, 1.24  0.04, and 0.87  0.03 (
S.E., n  7), respectively (24, 26). Upon completion of spectral acquisi-
tion, the heart was freeze-clamped at liquid nitrogen temperature.
Tissue was ground to a powder in liquid nitrogen and stored at 80 °C
for later enzymatic analysis of tissue ATP concentration and total
creatine (24, 26).
For skeletal muscle, radiofrequency pulses of 8-s duration at an
approximate 90° flip angle were applied with a 1-s interpulse delay (24,
26). FIDs were acquired over 0.8 s with a total of 256 FIDs averaged. A
6000-Hz spectral width was used, and 9600 data points were obtained.
In contrast to heart spectra, a line-fitting program was not required for
muscle because of the superior signal to noise ratio. The partially
relaxed 31P spectra were calibrated by comparison with fully relaxed
spectra using the same process described for heart. In muscle, the mean
correction factors for Pi, phosphocreatine, and -ATP were 0.98  0.10,
1.03  0.01, and 0.88  0.09 ( S.E., n  6), respectively. Upon
completion of spectral acquisition, the muscle was freeze-clamped, and
the tissue was powdered in liquid nitrogen for enzymatic determination
of ATP, total creatine, pyruvate, and P-enolpyruvate contents. The
extraction procedures are described by Hitchins et al. (24).
Free [ADP] was calculated using the creatine kinase equilibria de-
scribed in detail by Cieslar and Dobson (25, 26). To convert mol/g to
mM intracellular water the spaces of Cieslar et al. (27) for rat heart and
skeletal muscle were used. The ATP measured enzymatically was
equated with the integral of the -ATP peak for both heart and muscle
spectra taking into account the saturation correction factors. The equa-
tions are described in detail in Hitchins et al. (24). Intracellular pH was
calculated from the chemical shift (, ppm) of Pi relative to phosphocre-
atine in the 31P spectra using the NMR version of the Henderson-
Hasselbalch equation, shown below.
pHi  6.75 log  3.255.69  (Eq. 1)
Intracellular free [Mg2] concentration ([Mg2]i) was calculated from
the observed chemical shift difference () in ppm between -phos-
phate and -phosphate resonances of ATP in the 31P spectra using the
modified form of the London equation (28), shown in Equation 2,
	Mg2
i KD1  1  23  4  1   (Eq. 2)
where   [H]/KH and   (KD/KD). KH is the dissociation constant
for the H/ATP4 equilibrium, KD is the dissociation constant for the
ATP4/Mg2 equilibrium, and KD is the dissociation constant for the
ATPH3/Mg2 equilibrium. The parameters 1, 2, 3, and 4 were
assigned published values of 10.600, 11.660, 8.165, and 8.52 ppm,
respectively, KD was 9.0  10
5 M, KH was 3.4  10
7 M, and KD was
7.2  104 M (24).
Statistical Significance—Values are reported as mean  S.E. Statis-
tical significance was assessed using a student’s t test or a two-way
repeated measured analysis of variance (ANOVA). The  level of sig-
nificance for all experiments was set at p  0.05.
RESULTS
Attainment of equilibrium was judged complete when the
apparent K, defined as [ATP][Pyr]/[ADP][P-enolpyruvate]
agreed to within 10% when approached from both directions.
The initial and final concentrations of reactants, experimental
pH, and free [Mg2] at 25° and the Kexperimental (calculated at
experimental conditions) and K (calculated at specified pH 7,
free [Mg2] 1.0 mM, and I  0.25 M are shown in Table I. The
average K in the forward direction was 37,821, and in the
reverse it was 37,618. The enthalpy (H°) of the pyruvate
kinase biochemical reaction in the ATP direction was 4.31
kJmol1 (Fig. 1) and calculated from the log K versus temper-
ature (1/T) where the slope of the line is equal to H°/2.303
R (R is the gas constant 8.314 J mol1K1). The corresponding
entropy (S°) was 73.4 J mol1K1. The equation for the line
in Fig. 1 was y  224.83X  3.833 (R2  0.97).
A similar plot was constructed for the chemical reaction
P-enolpyruvate3  ADP3  H  ATP4  Pyr1, and the
enthalpy and entropy values for the reaction were 6.43 kJ-
mol1 and 190 J mol1K1, respectively. The equation of the
line was y  335.99X  9.934 (R2  0.90) (plot not shown).
When the magnesium-bound reactants are used in the chemi-
cal reaction (MgP-enolpyruvate1  MgADP1  H 
MgATP2  MgPyr1), the enthalpy and entropy were 4.10
kJmol1 and 207 J mol1K1, respectively. The equation of
the line was y  214.12X  10.798 (R2  0.88) (plot not shown).
The thermodynamic data for the different forms of the pyru-
vate kinase reaction, including the G° and equilibrium con-
stants, are summarized in Table II. The effect of pH on the
pyruvate kinase equilibrium is shown in Fig. 2. As pH varied
from 6.40 to 7.8 at free [Mg2] of 1.0 mM, I  0.25 M, and 25 °C,
the K for pyruvate kinase decreased by a factor of 10 (from
around 100,000 to 10,000). It is also noteworthy that at lower
pH the standard errors increased because of the very large
equilibrium constants and decreasing micromolar concentra-
tions of P-enolpyruvate and ADP.
The concentration of reactants of the pyruvate kinase reac-
TABLE I
Attainment of equilibrium from the forward and reverse directions for the pyruvate kinase reaction at 25 °C
Average KAK forward direction  37821  628 (S.E.) (n  3). Average KAK reverse direction  37618  1394 (S.E.) (n  3). Percent difference 
1.0% (see “Results” for further discussion). K is the apparent biochemical equilibrium constant at pH 7.0, free [Mg2].
Initial Concentrations Final Concentrations
KPKex
K (pH 7.0, free
[Mg2]  1.0 mM,
I  0.25 M)[ADP] [PEP] [ATP] [Pyr] [ADP] [PEP] [ATP] [Pyr] pH Free[Mg]
103 M 25 °C, 103 M
Forward direction PEP  ADP  Pyr  ATP
0.50 0.50 4.30 4.70 0.133 0.0056 4.65 5.18 6.989 0.618 32016 36662
0.50 0.50 4.30 4.70 0.133 0.0054 4.67 5.21 6.980 0.616 33750 37986
0.50 0.50 4.30 4.70 0.126 0.0056 4.82 5.01 6.980 0.591 34057 38816
Reverse direction Pyr  ATP  PEP  ADP
0 0 5.0 5.10 0.137 0.0050 4.84 5.11 6.940 0.557 36415 39216
0 0 5.0 5.10 0.134 0.0052 4.70 5.13 6.940 0.543 34439 34843
0 0 5.0 5.10 0.127 0.0054 4.79 5.04 6.950 0.564 35392 38795













tion in rat heart and gastrocnemius skeletal muscle in situ are
shown in Table III. The pH and free [Mg2] were estimated
from 31P NMR and found to be 7.32 and 7.18 mM and 0.46 and
0.57 mM for heart and skeletal muscle, respectively (Table III).
Free [ADP] was calculated from the creatine kinase equilib-
rium using the reactants reported in Table III and was found to
be 0.04 and 0.02 mM, respectively in heart and skeletal muscle.
Using free ADP and measuring P-enolpyruvate, ATP, and Pyr
in the tissues the mass action ratio was 4,382 for the pyruvate
kinase biochemical reaction in heart and 3,050 in rat gastro-
cnemius. These values were compared with the calculated K of
13,230 and 18,880 for heart and muscle, respectively (Table
IV).
DISCUSSION
Thermodynamics of the Pyruvate Kinase Reaction—Over the
past 40 years knowledge of the thermodynamics of the pyru-
vate reaction has relied to a very large extent on the early
studies of McQuate and Utter (7). The equilibrium is complex,
because the reaction lies very far to the right making it tech-
nically difficult to measure low levels of P-enolpyruvate and
ADP in the presence of high concentrations of pyruvate. Using
methodologies and a system of equations described in earlier
studies, we report an enthalpy (H°) for the biochemical reac-
tion (Reaction 1) of 4.31 kJmol1 over the temperature range
of 5 to 45 °C. This enthalpy value is in good agreement with the
recalculated value of 4.7 kJmol1 (pH 8.03, 25 °C) in the
calorimetric study of Cheer et al. (29) (see Goldberg and Tew-
ari; 30). A low negative H° shows that the pyruvate kinase
reaction is predominately entropically driven in the ATP direc-
tion, with the enthalpy term contributing only 16% to the
overall G° (Table II). This is in contrast to the thermodynam-
ics of the creatine kinase and arginine kinase biochemical
reactions, which are predominately enthalpy-driven (19, 20,
31). The differences demonstrate that pyruvate kinase reaction
has very different transphosphorylation mechanisms compared
with creatine kinase or arginine kinase. The relationship be-
tween K and Kref can be used to calculate K for the pyruvate
kinase reaction at differing pH and free [Mg2] over the phys-
TABLE II
Thermodynamic properties of the pyruvate kinase reaction
All values are at I  0.25 M. The percentages in parentheses for enthalpy and TS term are relative to the Gibbs energy.
Biochemical reaction
KPK














PEP  ADP 7 Pyr  ATP 3.89  104 26.2 4.31 (16%) 73.4 21.9 (84%)













PEP3  ADP3  H 7 ATP4  Pyr 1.09  1011 63.0 6.43 (10%) 190 56.7 (90%)
MgPEP1  MgADP1  H 7 MgATP2  MgPyr 3.24  1011 65.7 4.10 (6%) 207 61.6 (94%)
FIG. 1. Van’t Hoff plot of the effect of temperature on the apparent equilibrium constant of the pyruvate kinase reaction (KPK).
Each value represents the mean  S.E. (n  6) at pH 7.0, free Mg2 of 1.0 mM, and ionic strength of 0.25 M at 5, 15, 25, and 35 and 45 °C. The
equation to the line was y  224.83X  3.833; R2  0.97. The standard apparent heat of the reaction, H°, was calculated from the slope of the
line (slope  H°/2.303 R, where R is the gas constant 8.314 J mol1 K1). The intercept of log K versus 1/T at 1/T  0 is equal to S°/2.303
R, where S° is defined as the standard apparent entropy of the reaction under the conditions defined. The standard apparent H° for the
pyruvate kinase reaction in the direction of ATP formation was 4.31 kJmol1 and S°  73.4 J K1mol1.













iological range at 38 °C and I  0.25 M. This relationship is
























where Kref is 9.53 10
10 at 38 °C, and the acid-dissociation and
magnesium binding constants are adjusted to 38 °C (23). The
Ka for P-enolpyruvate (HP-enolpyruvate
2  P-enolpyruvate3
 H) was 4.2  107 at 38 °C and I  0.25, and the magne-
sium binding constant for P-enolpyruvate (KbP-enolpyruvate
1)
(Mg2  P-enolpyruvate3  MgP-enolpyruvate1 was 2.2 
102 at 38 °C and I  0.25 M. Values for K at different pH and
free [Mg2] over the physiological range is presented in Table
V.
Physiological Significance of the Thermodynamic Data and
Reversal of Glycolysis—Most biochemical texts refer to the
pyruvate kinase reaction as a highly exergonic reaction posi-
tioned far from equilibrium (11, 16, 32). Newsholme and Start
(33) in Regulation in Metabolism state, “The mass action ratio
for pyruvate kinase indicate that this enzyme catalyzes a re-
FIG. 2. Variation of KAK with pH. Each point represents the mean  S.E. (n  6), T  25 °C, free [Mg
2]  1.0 mM, and I  0.25 M. (see
“Materials and Methods” for details).
TABLE III
Calculation of free cytosolic [ADP] in rat heart and gastrocnemius skeletal muscle in vivo
All metabolites are expressed in mM intracellular water. Free cytosolic [ADP] was calculated using the creating kinase equilibrium (see
“Materials and Methods”). [Creatine] was calculated by [Total Creatine]  [Phosphocreatine]. Conversion of total tissue content (mol/g wet
weight) into intracellular concentrations (mol/ml) was performed using total tissue water (g/g wet weight) and intracellular space in vivo values
of 0.79 and 0.581 (73%) for the rat heart and 0.76 and 0.64 (84%) for gastrocnemius muscle (22). Values are mean  S.E.
Tissue n pH Free [Mg2] KCK ATP PCr Total Cr Cr Free [ADP]
Heart 7 7.32  0.04 0.46  0.03 65  8 8.28  0.31 17.0  0.28 22.3  0.9 5.30  1.07 0.04  0.007
Skeletal muscle 7 7.18  0.015 0.57  0.02 95  4 9.45  0.26 36.5  1.70 44.6  1.0 8.10  1.23 0.02  0.005
TABLE IV
Assessment of the position of the pyruvate kinase equilibrium in rat heart and gastrocnemius skeletal muscle in vivo
Tissue mass action ratios are expressed in the ATP direction and compared with the apparent KPK adjusted to tissue pH and free [Mg
2] at 38 °C
and I  0.25 M. All metabolites are expressed in mM  S.E. Free [ADP] was calculated from the creatine kinase equilibrium (see Table III and
“Materials and Methods”). Conversion of total tissue content (mol/g wet weight) into intracellular concentrations (mol/ml) was performed using
total tissue water (g/g wet weight) and intracellular space in vivo values of 0.79 and 0.581 (73%) for the rat heart and 0.76 and 0.64 (84%) for
gastrocnemius muscle (27).
Tissue n ADP PEP ATP Pyr Tissue mass action ratio[Pyr][ATP]/[PEP][ADP]
KPK adjusted to pH
and free [Mg2] of
heart and muscle
mM
Heart 7 0.04  0.008 0.010  0.002 8.28  0.82 0.11  0.009 4,382  1550 13,230 (3-fold)
Skeletal muscle 6 0.02  0.005 0.018  0.002 9.45  0.68 0.11  0.009 3,050  533 18,880 (6.2-fold)













action which is removed from equilibrium.” Albert Lehninger
(34) in Principles of Biochemistry wrote, “The (PK) reaction also
tends to go far to the right under standard conditions because
the G° P-enolpyruvate is much larger than G° ATP hydrol-
ysis. The reaction is irreversible in the cell.” More recently Voet
et al. (35) in Fundamentals of Biochemistry wrote, “Only three
reactions, those catalyzed by hexokinase, phosphofructokinase
and pyruvate kinase, . . . are nonequilibrium reactions of gly-
colysis and candidates for flux control points.”
Our study shows that the pyruvate kinase reaction is poised
much closer to near-equilibrium than believed previously. On
the basis of NMR and metabolic measurements, the mass ac-
tion ratio in heart and resting skeletal muscle is only 3- to
6-fold from the equilibrium constant of the reaction determined
on the bench and adjusted to the same pH, free [Mg2], and
temperature of the tissues (see Tables IV and V). The mass
action ratio calculation assumes that all the measured or cal-
culated reactants in situ are thermodynamically free with no
binding, or compartmentation occurs in the tissue. The striking
aspect of the comparison is the close agreement reached be-
tween the observed and theoretical constants in heart and
skeletal muscle. The thermodynamic data indicate that a fall in
intracellular pH (and a rise in free [Mg2]), such as during high
intensity exercise, hypoxia, or ischemic injury, would lead to
the equilibrium shifting further to the right. If the pH fell by
0.6 units (7.3 to 6.7), and free [Mg2] rose by 0.2 mM (0.5 to 0.7
mM), the equilibrium position would increase over 3-fold from
around 14,000 to 45,000 (Table V). Conversely during recovery,
as tissue pH and free [Mg2] returned to “resting” values, the
equilibrium position would be poised much closer to near-equi-
librium. Thus, on the basis of our thermodynamic analysis, we
propose that the equilibrium position during anaerobic exercise
would favor strongly ATP and pyruvate formation, and during
recovery it would be more favorable to permit replenishment of
glycogen stores.
However, the thermodynamics (i.e. the extent and direction
of a reaction) is not the only consideration required to assess
the role of pyruvate kinase in the reversal of glycolysis in intact
tissues. Another important factor is kinetic constraints over
the activity of the enzyme. If the activity of pyruvate kinase is
not sufficiently high, reversal may be limited kinetically, even
if the equilibrium is favorable. In support of the earlier work of
Lardy and Ziegler (4), Krimsky (6), and McQuate and Utter (7),
Dyson et al. (8) have shown that the reversal of pyruvate kinase
and glycolysis is kinetically feasible in muscle. Using a coupled
reaction that removed P-enolpyruvate, they showed that the
enzyme could catalyze the phosphorylation of pyruvate at a
maximum velocity of about 6 mol min1 mg1 (6, 8). Dyson et
al. (8) further noted that given the high activity in skeletal
muscle, the physiological significance of the reverse reaction of
pyruvate kinase in muscle has been underestimated, particu-
larly its role in glycogen synthesis (8). Newsholme and Start
(33) also noted the extremely high maximal activity of pyruvate
kinase relative to the rate-controlling phosphofructokinase in
muscle, heart, and brain extracts (up to 10-fold higher), which
suggests that the enzyme must be strongly inhibited, particu-
larly in muscle. The maximal activity of pyruvate kinase in rat
and rabbit gastrocnemius is about 800 and 1100 mol of sub-
strate g1 wet wt min1, respectively (36). Because there is
around 2 mg of enzyme per g wet weight muscle, the reverse
rate of Dyson et al. (8) equates to 12 mol min1 g1 wet weight
muscle, which is around 1 to 2% of the maximal velocity of the
enzyme.
Having argued that the thermodynamics and kinetics of
pyruvate kinase are favorable under some conditions, an im-
portant question remains: “How does the rate of pyruvate ki-
nase reversal compare with the observed rate of glycogen syn-
thesis in skeletal muscle following exercise?” The highest
glycogen synthesis rate from lactate following short term high
intensity exercise was reported by Hermansen and Vaage (13)
in human quadriceps. They reported a value of 0.56 mol
glucosyl units g1 wet wt min1 muscle, which translates to
about 17 mol g1 during 30 min of recovery after three bouts
of maximal cycling (13). In contrast, following prolonged aero-
bic exercise, this rate of glycogen resynthesis is over an order of
magnitude lower with rates ranging from 0.025 to 0.03 mol
glucosyl units g1 wet wt min1 muscle (37). Even at the
highest reported glycogen resynthesis rates, the estimate of
Dyson et al. (8) of 12 mol min1 g1 wet weight muscle for
pyruvate phosphorylation is ample to explain the observed
rates of glycogen synthesis in vivo.
McLane and Hollozy (14) also argued that pyruvate kinase
reversal could account for glycogen formation from lactate in
three types of rat skeletal muscle, as has Hochachka and col-
leagues (38) in fish white muscle, which, like other muscles,
lacks the bypass enzymes pyruvate carboxylase and P-enol-
pyruvate carboxykinase. More recently, Donovan and Paglias-
sotti (18) also have concluded that PEPCK is not involved in
mammalian skeletal muscle glyconeogenesis and concluded
pyruvate must be reversed to explain the rates of glycogen
replenishment. They suggested that P-enolpyruvate formation
in skeletal muscle glyconeogenesis occurs by reversal of the
pyruvate kinase reaction (18). On the basis of the available
literature, and because malic enzyme appears to thermody-
namically favor the decarboxylation of malate to pyruvate (39),
it is now generally believed that malic enzyme, malate dehy-
drogenase, and P-enolpyruvate carboxykinase are specific to
glucogenic tissues such as liver and kidney and not skeletal
muscle or heart. However, the thermodynamics of the pyruvate
kinase reaction reported in this study apply equally to all
tissues. What remains to be established is the mass action
ratios in liver and kidney.
On the question of the role of pyruvate kinase and the rever-
sal of glycolysis in situ, it would appear that intracellular pH
TABLE V
Effect of pH and free Mg2 concentrations on KPK at 38 °C and I  0.25 M. KPK  [Pyr][ATP]/[PEP][ADP]
pH
Free [Mg2] (mM)
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 1.1 1.2 1.3
6.4 22951 31021 38033 44153 49517 54234 58395 62073 65331 68223 70792 73076 75108 76916
6.5 19890 27731 34450 40238 45247 49600 53395 56712 59617 62166 64405 66373 68103 69623
6.6 17021 24451 30732 36076 40647 44573 47958 50885 53421 55622 57534 59195 60637 61889
6.7 14398 21272 27010 31835 35917 39387 42347 44881 47055 48921 50525 51903 53086 54099
6.8 12054 18272 23404 27674 31251 34262 36807 38965 40799 42359 43686 44813 45770 46579
6.9 10000 15513 20016 23728 26810 29382 31538 33352 34879 36167 37252 38165 38931 39571
7.0 8231 13031 16918 20095 22712 24881 26685 28191 29450 30503 31383 32117 32726 33229
7.1 6730 10845 14151 16835 19030 20838 22332 23572 24601 25456 26165 26751 27234 27628
7.2 5473 8953 11730 13972 15795 17288 18515 19528 20364 21054 21623 22090 22471 22778
7.3 4430 7340 9649 11504 13005 14228 15230 16052 16728 17283 17738 18109 18409 18649
7.4 3573 5982 7886 9409 10636 11633 12446 13110 13654 14099 14462 14756 14993 15181













and free [Mg2] must return to, or at least approach, pre-
exercise or pre-ischemic values, before the equilibrium favors
reversal. Otherwise at low pH or high free [Mg2], the equilib-
rium position will work against pyruvate phosphorylation and
therefore glycogen synthesis. Future studies are required to
test this hypothesis to achieve the full physiological signifi-
cance of the thermodynamic and kinetic properties of pyruvate
kinase. Of the twelve reactions that comprise the glycogeno-
lytic pathway, nine have traditionally been considered near-
equilibrium, and three are displaced far from equilibrium. The
three non-equilibrium reactions are glycogen phosphorylase
(EC 2.4.1.1), phosphofructokinase-I (EC 2.7.1.11), and pyru-
vate kinase. Our thermodynamic data show that the pyruvate
kinase reaction is much closer to equilibrium in resting skeletal
muscle and heart than otherwise believed and implies regula-
tory control of glycogenolysis at the glycogen phosphorylase
and phosphofructokinase steps and at hexokinase and phos-
phofructokinase steps in the case of glycolysis. Finally, around
30 years ago Newsholme and Start (33) recognized some of the
paradoxical aspects of pyruvate kinase when they wrote, “An-
other problem enzyme is pyruvate kinase; the mass action ratio
strongly indicates that it catalyzes a non-equilibrium reaction
whereas its maximal catalytic activity suggests otherwise.”
Our study indicates that, under some circumstances, the pyru-
vate kinase reaction can approach near-equilibrium and that
the high maximal activity is significant to the reverse reaction
and glycogen replenishment.
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